Rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation - Mahaffey, KW; Fox, KA (American Heart Association, 2010)
Accessed April 27, 2012.